Home › All Companies › APRE › Annual Report

Aprea Therapeutics, Inc. (APRE) — Annual Report

AI-Powered SEC Filing Analysis

← All APRE filings
Latest Annual Report Filed: 2026-03-16

Key Insights

  • Aprea Therapeutics, Inc. reported a significant increase in revenue and earnings in fiscal year 2025 compared to the prior year.
  • The company completed two At-the-Market offerings in 2024 and 2025, raising additional capital to fund ongoing research and development activities.
  • Aprea Therapeutics announced a private placement in January 2026 with certain investors, providing additional funding to support the business.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-16. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Aprea Therapeutics, Inc.

Current Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.